Breath test could help prevent brain damage in jaundiced newborns
NCT ID NCT06832800
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a new method to diagnose and treat severe jaundice in newborns. The method uses a non-invasive breath test (ETCOc) to detect hemolysis, a common cause of jaundice. Researchers will compare this approach to standard care in 250 newborns to see if it reduces the risk of brain damage by age one.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
modified diagnosis and treatment (MDT) method including ETCOc measurement
What this could lead to
If it works, this could lead to a better way to prevent brain damage in newborns with severe jaundice.
What could go wrong
This is a very early (Phase 1) trial with only 250 participants, so results may not be conclusive. The new method may not prove better than current care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL HYPERBILIRUBINEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Women's Hospital School of Medicine Zhejiang University
RECRUITINGHangzhou, China
Contact Phone: •••-•••-••••